Epithelial to Mesenchymal Transition in Cyclosporine A-Induced Rat Gingival Overgrowth
Fei Yang,Jing Lu,Youcheng Yu,Yiming Gong
DOI: https://doi.org/10.1016/j.archoralbio.2017.04.024
IF: 2.64
2017-01-01
Archives of Oral Biology
Abstract:Background and objective: Epithelial-mesenchymal transition (EMT) has been proved to occur in drug-induced gingival overgrowth. However, the specific pathogenic mechanism remains uncertain. The aim of this study is to examine the expression of EMT markers in cyclosporine A (CsA)-induced gingival overgrowth in rat models.Material and methods: Thirty-six rats were randomly divided into two groups. The experimental group received CsA therapy subcutaneously in a daily dose of 10 mg/kg, and the other group was used as a control. Six rats per group were sacrificed at 20, 40 and 60 days, and the gingivae were obtained. The expression of TGF-beta 1, E-Cadherin, ZEB1, ZEB2, and Snaill were examined by quantitative real time PCR (qRT-PCR), western blotting, and immunohistochemistry. In addition, a group of microRNAs associated with EMT and fibrosis were also detected in gingival tissue by qRT-PCR.Results: The mRNA and protein levels of TGF-beta 1, ZEB1, and ZEB2 in gingivae were significantly upregulated after 40 and 60 days of CsA administration. Conversely, the levels of E-cadherin were significantly down regulated in overgrowth sample at day 40 and 60. Intense immunohistochemmical staining for TGF-beta 1 were observed in the samples from CsA group at day 40 and 60. Concomitantly, the densities of E-cadherin were gradually decreased in the basal layers of epithelium with time. Three members of miR-200 s (miR-200a, miR-200b and miR-200c) were significantly downregulated in CsA-treated rats at 40 and 60 days, while miR-9, miR-23a and miR-155 were significantly upregulated when compared with those of the control group.Conclusions: The process of EMT in CsA-induced rat gingival overgrowth is associated with increased expression of TGF-beta 1, ZEB1, and ZEB2, and decreased expression of E-cadherin.